FURP.ORG / PUBLIC DATA EXPLORER

LUPUS RESEARCH ALLIANCE INC: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
LUPUS RESEARCH ALLIANCE INC (EIN 58-2492929)
Tax period
2019-01-01 to 2019-12-31
Filed
2020-11-12
IRS object ID
202023179349301882
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2020-11-12T08:56:10-06:00ReturnTs
Tax Period End2019-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN131655065PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1LUTZ AND CARR CPAS LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1551 FIFTH AVENUE SUITE 400AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10176ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN582492929EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1LUPUS RESEARCH ALLIANCE INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlLUPUBusinessNameControlTxt
Phone2122182840PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1275 MADISON AVE 10TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonDEBRA ROSEPersonNm
Person TitleCHIEF FIN. AND ADMIN. OFFICERPersonTitleTxt
Phone2122182840PhoneNum
Signature2020-11-11SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonLAUREN CRESCIPreparerPersonNm
PTINP01268493PTIN
Phone2126972299PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address38.142.140.186IPv4AddressTxt
FieldValueIRS element (for citing)
IP2020-11-11IPDt
IP Tm16:18:36IPTm
IP TimezoneESIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdC6B84DD1F518B96753207BD5099AA33ACBC10C80AtSubmissionCreationDeviceId
At Submission Filing Device IdA75ECF90F4EA679C298DF903E96775B34A8C9CB0AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerKENNETH M FARBERPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1275 MADISON AVE 10TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$30,394,667GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressLUPUSRESEARCH.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1999FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionTO SUPPORT RESEARCH TO PREVENT, TREAT AND CURE LUPUS.ActivityOrMissionDesc
Voting Members Governing Body21VotingMembersGoverningBodyCnt
Voting Members Independent21VotingMembersIndependentCnt
Total Employee52TotalEmployeeCnt
Total Volunteers500TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$15,396,535PYContributionsGrantsAmt
CY Contributions Grants$17,673,622CYContributionsGrantsAmt
PY Program Service Revenue$1,334,475PYProgramServiceRevenueAmt
CY Program Service Revenue$1,236,449CYProgramServiceRevenueAmt
PY Investment Income$2,296,486PYInvestmentIncomeAmt
CY Investment Income$2,148,621CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$19,027,496PYTotalRevenueAmt
CY Total Revenue$21,058,692CYTotalRevenueAmt
PY Grants And Similar Paid$11,290,811PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$15,505,548CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$4,888,001PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$5,172,935CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$49,000PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$49,000CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$3,029,588CYTotalFundraisingExpenseAmt
PY Other Expenses$6,635,816PYOtherExpensesAmt
CY Other Expenses$6,083,559CYOtherExpensesAmt
PY Total Expenses$22,863,628PYTotalExpensesAmt
CY Total Expenses$26,811,042CYTotalExpensesAmt
PY Revenues Less Expenses-$3,836,132PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$5,752,350CYRevenuesLessExpensesAmt
Total Assets BOY$65,079,955TotalAssetsBOYAmt
Total Assets EOY$71,431,718TotalAssetsEOYAmt
Total Liabilities BOY$23,818,659TotalLiabilitiesBOYAmt
Total Liabilities EOY$26,661,517TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$41,261,296NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$44,770,201NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE LUPUS RESEARCH ALLIANCE LEADS THE WORLD IN TRANSFORMING THE LIVES OF PEOPLE AFFECTED WITH LUPUS BY USING THE POWER OF SCIENCE TO DRIVE NEW TREATMENTS, PREVENT DISEASE PROGRESSION, AND FIND A CURE.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$11,776,654ExpenseAmt
Grant$10,878,438GrantAmt
DescRESEARCH:THE LUPUS RESEARCH ALLIANCE IS THE LARGEST NON-GOVERNMENTAL, NON-PROFIT FUNDER OF LUPUS RESEARCH WORLDWIDE. THE ORGANIZATION AIMS TO TRANSFORM TREATMENT WHILE ADVANCING TOWARD A CURE BY FUNDING THE MOST INNOVATIVE LUPUS RESEARCH, FOSTERING DIVERSE SCIENTIFIC TALENT, AND DRIVING DISCOVERY TOWARD BETTER DIAGNOSTICS, IMPROVED TREATMENTS AND ULTIMATELY A CURE FOR LUPUS. THE ORGANIZATION'S RESEARCH COMMITTEE OF THE BOARD OF DIRECTORS AND SCIENTIFIC ADVISORY BOARD ARE COMPRISED OF TOP SCIENTIFIC EXPERTS WHO WORK WITH STAFF TO STRATEGICALLY GUIDE AND DRIVE THE RESEARCH FUNDING AGENDA. SINCE ITS INCEPTION, THE LUPUS RESEARCH ALLIANCE HAS COMMITTED OVER $202 MILLION TO FUND LUPUS RESEARCH PROJECTS. IN 2019 ALONE, NEARLY $11 MILLION WAS AWARDED IN GRANTS FOR HIGHLY INNOVATIVE PROJECTS WITH THE POTENTIAL TO IMPROVE TREATMENT AS WELL AS UNDERSTAND THE CAUSES OF LUPUS THAT CAN LEAD TO A CURE: 1) A NEW INVESTIGATOR INITIATED CLINICAL TRIAL AWARD WAS MADE IN 2019 FOR OVER $2.5 MILLION OVER THREE YEARS THAT WILL EVALUATE THE EFFICACY OF ACE INHIBITORS IN COGNITIVE IMPAIRMENT ASSOCIATED WITH SLE. 2) 6 TARGET IDENTIFICATION IN LUPUS (TIL) THREE-YEAR GRANTS WITH A FOCUS OF IDENTIFYING NEW DRUG TARGETS AND HELPING FACILITATE EXPLORATION OF DRUG DEVELOPMENT WITH A TOTAL NEARLY $3.6 MILLION OVER THREE YEARS; 3) 6 NOVEL RESEARCH PROGRAM GRANTS THAT FOCUS ON INNOVATIVE EARLY-STAGE FUNDAMENTAL RESEARCH THAT ILLUMINATE THE DISEASE MECHANISM; AWARDED $1.8 MILLION OVER THREE YEARS;4) 2 DISTINGUISHED INNOVATOR AWARDS (DIA) FOCUS ON UNCOVERING THE UNDERLYING CAUSES OF LUPUS THAT CAN LEAD TO A CURE FOR $1 MILLION OVER TWO YEARS5) JOINT LUPUS RESEARCH ALLIANCE/PFIZER'S CENTERS FOR THERAPEUTIC INNOVATION (CTI) GRANTS WERE AWARDED FOR OVER $250,000 FOR ONE YEAR6) THE LUPUS INSIGHT PRIZE WAS AWARDED FOR $100,000. THIS AWARD RECOGNIZES AND FURTHERS WORK BY A LEADING RESEARCHER WHO HAS MADE A MAJOR CONTRIBUTION TO THE FIELD.7) THE LUPUS RESEARCH ALLIANCE SUPPORTED THE WORK OF THE LUPUS NEPHRITIS TRIALS NETWORK WITH A $200,000 AWARD - SUPPORTING COLLABORATIONS TO IDENTIFY AND VALIDATE THERAPEUTIC TARGETS FOR LUPUS NEPHRITIS.8) IN ADDITION, NEARLY $400,000 WAS FUNDED ON A STRATEGICALLY FOCUSED NON-PEER REVIEWED EFFORT TO HELP IDENTIFY WHERE LUPUS PATIENTS ARE IN THE US.THE LUPUS RESEARCH ALLIANCE'S UNIQUE FUNDING MODEL SUPPORTS PROMISING RESEARCH EFFORTS WITH THE GOAL OF IMPROVING THE LIVES OF PEOPLE WITH LUPUS IN THE NEAR FUTURE. THROUGH A COMPETITIVE PEER-REVIEW PROCESS PROJECTS BY THE LUPUS RESEARCH ALLIANCE AIM TO TRANSLATE RESULTS FROM THE RESEARCH BENCH TO THE BEDSIDE AS QUICKLY AS POSSIBLE. BECAUSE THE LUPUS RESEARCH ALLIANCE BOARD OF DIRECTORS FUNDS THE ADMINISTRATIVE AND FUNDRAISING EXPENSES, 100% OF ALL OTHER CONTRIBUTIONS GOES TO SUPPORT THE LUPUS RESEARCH ALLIANCE'S LUPUS RESEARCH PROGRAMS.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$8,906,496ExpenseAmt
Grant$4,625,282GrantAmt
Revenue$1,236,449RevenueAmt
DescSCIENTIFIC PROGRAMS:2019 WAS A YEAR OF CONSIDERABLE ACTIVITY WITHIN LUPUS RESEARCH ALLIANCE'S (LRA) SCIENTIFIC PROGRAM WITH THE IMPLEMENTATION OF LRA'S SCIENTIFIC STRATEGIC PLAN FOCUSING ON HETEROGENEITY. THE LUPUS RESEARCH ALLIANCE ENCOURAGES CROSS-SECTOR AND CROSS-DISCIPLINE PARTNERSHIPS TO FOSTER THE MOST INNOVATIVE AND PRODUCTIVE RESEARCH ENVIRONMENT. IN 2019, COLLABORATIVE MEETINGS WERE FUNDED BY THE LUPUS RESEARCH ALLIANCE WHERE RESEARCHERS WERE ENCOURAGED TO EXCHANGE IDEAS AND HELP THE LUPUS RESEARCH ALLIANCE TARGET NEW RESEARCH OPPORTUNITIES. THIS INCLUDED THE: ANNUAL FORUM FOR DISCOVERY WHERE FUNDED SCIENTISTS AND GUESTS SHARE THEIR PROGRESS; RESEARCH COMMITTEE MEETINGS WHERE MEMBERS OF OUR BOARD OF DIRECTORS AS WELL AS TOP-LEVEL RESEARCHERS DISCUSSED OUR PORTFOLIO AND UPCOMING STRATEGIC STEPS; SCIENTIFIC ADVISORY BOARD MEETINGS WHERE OUR ADVISORS REVIEW GRANT APPLICATION SUBMISSIONS AND DISCUSS FUTURE OVERALL RESEARCH STRATEGY FOR THE ORGANIZATION; LUPUS INDUSTRY COUNCIL MEETINGS WHERE INDUSTRY FOCUSES ON SOLVING SHARED OBSTACLES TO CLINICAL TRIALS; PATIENT RESEARCH AND ADVOCACY MEETINGS THAT ENGAGE THE LUPUS COMMUNITY IN UNDERSTANDING, PARTICIPATING IN AND ADVOCATING FOR RESEARCH FUNDING; AND LUPUS CLINICAL INVESTIGATORS NETWORK (LUCIN) MEETINGS WHERE TOP RESEARCHERS DISCUSS THE DESIGN AND PROGRESS FOR LUPUS CLINICAL TRIALS. THE LUPUS RESEARCH ALLIANCE FOUNDED LUPUS THERAPEUTICS, LLC AS AN AFFILIATE OF THE LRA IN 2018 TO RUN LUCIN TO ADVANCE CLINICAL TRIALS AND FACILITATE THE DEVELOPMENT OF MUCH NEEDED NEW LUPUS TREATMENTS. THE LUPUS RESEARCH ALLIANCE PROVIDED NEARLY $4.5 MILLION IN GRANTS TO TOP ACADEMIC CENTERS TO FOSTER CLINICAL TRIAL PARTICIPATION IN LUCIN. LUPUS THERAPEUTICS (LT) CONTINUES TO HAVE A DIVERSE PORTFOLIO OF ONGOING CLINICAL TRIALS WITHIN LUCIN AND HAS COMPLETED ENROLLMENT MILESTONES FOR FIVE CLINICAL TRIALS AND REPORTED RESULTS FOR ONE TRIAL. MOREOVER, LT HAS A HEALTHY PIPELINE OF NEW BUSINESS DEVELOPMENT DISCUSSIONS WITH INDUSTRY RELATED TO PERFORMING ADVISORY SERVICES AND/OR CONDUCTING PROSPECTIVE CLINICAL TRIALS WITHIN THE NETWORK. IN 2019, THERE WERE ELEVEN ACTIVE STUDIES MANAGED VIA LUPUS THERAPEUTICS IN CONJUNCTION WITH THE LUCIN NETWORK WITH OBJECTIVES RANGING FROM;- EVALUATING THE SAFETY AND EFFICACY OF BRAND-NEW THERAPEUTICS FROM 6 DIFFERENT INDUSTRY PARTNERS- EVALUATING THE BENEFITS OF USING TIMED-RELEASED PREDNISONE - USING MRI TECHNOLOGY TO ASSESS LUPUS NEPHRITIS - TESTING THE BENEFITS OF KRILL OIL AS A MEDICAL FOOD- TESTING A SMARTPHONE APP THAT ALLOWS LUPUS PATIENTS TO REPORT SYMPTOMS IN REAL TIME AND PROVIDE MORE INFORMATION TO THEIR DOCTORS MORE EASILY. THE LUPUS RESEARCH ALLIANCE'S FORUM FOR DISCOVERY WAS A THREE DAY MEETING WITH OVER 120 DEDICATED RESEARCH SCIENTISTS, PHARMACEUTICAL INDUSTRY REPRESENTATIVES, AND LUPUS RESEARCH ALLIANCE ADVOCATES AND PARTNERS FOCUSED ENTIRELY ON LUPUS RESEARCH FOR THE THREE DAYS AT THIS ANNUAL SCIENTIFIC CONFERENCE. ALL LRA- FUNDED RESEARCHERS WERE GIVEN THE OPPORTUNITY TO PRESENT BY POSTER OR PRESENTATION THEIR MOST UP-TO-DATE RESEARCH, WHILE THE RICH DISCUSSIONS SERVED AS AN INCUBATOR TO SPARK IDEAS FOR NEW RESEARCH DIRECTIONS. IN ADDITION TO THE MANY EXCITING ADVANCES SHARED, ATTENDEES RETURNED TO THEIR LABS INSPIRED BY CRITICAL INSIGHTS FROM THE DISTINGUISHED KEYNOTE SPEAKERS.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$846,235ExpenseAmt
Grant$1,828GrantAmt
DescPUBLIC POLICY:THE MAIN GOALS OF THE LUPUS RESEARCH ALLIANCE PUBLIC POLICY PROGRAM ARE TO: EDUCATE MEMBERS OF CONGRESS ABOUT ISSUES OF PRIORITY TO THE LUPUS COMMUNITY; INCREASE FEDERAL FUNDING FOR LUPUS RESEARCH BY INCREASING OVERALL NATIONAL INSTITUTES OF HEALTH (NIH) FUNDS, AND SECURE ADDITIONAL FUNDING FOR LUPUS RESEARCH THROUGH OTHER KEY FEDERAL AGENCIES INCLUDING THE VETERANS ADMINISTRATION AND DEPARTMENT OF DEFENSE (DOD). VOLUNTEERS ACROSS THE COUNTRY HELP AMPLIFY THESE OUTREACH EFFORTS.THROUGH THE LUPUS RESEARCH ALLIANCE ONGOING PUBLIC POLICY PROGRAM EFFORTS, SIGNIFICANT FUNDING FOR LUPUS RESEARCH HAS BEEN OBTAINED UNDER THE DEPARTMENT OF DEFENSE (DOD) CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS (CDMRP) OPERATED BY THE ARMY MEDICAL RESEARCH AND MATERIEL COMMAND. FIRST, THE LUPUS RESEARCH ALLIANCE WAS RESPONSIBLE FOR PERSUADING CONGRESS TO INCLUDE LUPUS IN ITS LIST OF DESIGNATED DISEASES ELIGIBLE FOR FUNDING OVER THE PAST TEN YEARS IN THE PEER REVIEWED MEDICAL PROGRAM. MOST RECENTLY, LUPUS RESEARCH ALLIANCE ADVOCACY SUCCEEDED IN THE ESTABLISHMENT IN 2017 OF THE LUPUS RESEARCH PROGRAM UNDER THE CDMRP. OVER THE PROGRAM'S FIRST THREE YEARS, $5 MILLION WAS EARMARKED EACH YEAR SPECIFICALLY FOR LUPUS; THROUGH THE LUPUS RESEARCH ALLIANCE'S CONTINUED EFFORTS THIS AMOUNT WAS INCREASED TO $10M IN THE DEFENSE HEALTH PROGRAM IN THE FY 2020 DEFENSE APPROPRIATIONS BILL AND IS AT $10M IN THE HOUSE DEFENSE APPROPRIATIONS BILL.IN 2017, THE LUPUS PATIENT-FOCUSED DRUG DEVELOPMENT (PFDD) INITIATIVE WAS LAUNCHED TO BRING THE VOICE OF THE PATIENT TO DRUG DEVELOPMENT. THIS COLLABORATIVE EFFORT WITH THE LUPUS AND ALLIED DISEASES ASSOCIATION (LADA) AND LUPUS FOUNDATION OF AMERICA (LFA) WAS DESIGNED TO PROVIDE THE FOOD AND DRUG ADMINISTRATION (FDA) WITH PERSPECTIVES FROM PEOPLE WITH LUPUS, ADVOCATES AND CAREGIVERS TO HELP INFORM THE FDA'S DECISIONS AND OVERSIGHT DURING THE DRUG DEVELOPMENT AND REVIEW PROCESSES. A REPORT WAS SENT TO THE FDA IN SPRING 2018. THE LRA CONTINUES TO WORK TO BRING THE VOICE OF THE PATIENT TO THE DRUG REVIEW PROCESS BY RESPONDING TO RELEVANT CALLS FROM THE FDA FOR COMMENTS. ONGOING ADVOCACY FOCUSES ON ENSURING LEGISLATION THAT SECURES THE FEDERAL FUNDING SUPPORT NECESSARY TO AFFORD INVESTIGATORS THE RESOURCES TO FOLLOW THROUGH WITH RESEARCH DISCOVERIES THAT WILL IMPROVE TREATMENT OF LUPUS. EVERY YEAR, THE LRA BRINGS ADVOCATES FROM ACROSS THE COUNTRY TO WASHINGTON DC FOR A DAY OF ADVOCACY TRAINING AND PRE-SCHEDULED MEETINGS WITH LEGISLATORS. THE GOAL IS TO INCREASE AWARENESS OF LUPUS AND THE IMPACT IT HAS ON PEOPLES' DAILY LIVES TO MEMBERS OF CONGRESS AND TO REQUEST THEIR SUPPORT FOR INCREASED FUNDING FOR LUPUS RESEARCH FROM FEDERAL PROGRAMS. TOMORROW'S ADVANCES DEPEND ON TODAY'S INVESTMENTS IN NIH RESEARCH.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$21,529,385TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional FundraisingYes (1)ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded EntityYes (1)DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document62IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee52EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members21GoverningBodyVotingMembersCnt
Independent Voting Member21IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1DEBRA ROSEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone6468846000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1275 MADISON AVE 10 FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (34 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
IRA AKSELRAD
CO-CHAIR1.00Yes (X)Yes (X)$0$0$0
RICHARD K DESCHERER
CO-CHAIR1.00Yes (X)Yes (X)$0$0$0
JOSEPH MAURIELLO
TREASURER1.00Yes (X)Yes (X)$0$0$0
BRENDA BLACKMON
SECRETARY1.00Yes (X)Yes (X)$0$0$0
NEIL J BURMEISTER
DIRECTOR1.00Yes (X)$0$0$0
JEROME CHAZEN
DIRECTOR1.00Yes (X)$0$0$0
THOMAS O DANIEL
DIRECTOR1.00Yes (X)$0$0$0
JENNIE DESCHERER
DIRECTOR1.00Yes (X)$0$0$0
KATIE DRISCOLL
DIRECTOR1.00Yes (X)$0$0$0
SIR MARC FELDMANN
DIRECTOR1.00Yes (X)$0$0$0
MOTI FERDER
DIRECTOR1.00Yes (X)$0$0$0
JOE GERMANOTTA
DIRECTOR1.00Yes (X)$0$0$0
DAVID KIES
DIRECTOR1.00Yes (X)$0$0$0
DANIEL LAVECCHIA
DIRECTOR1.00Yes (X)$0$0$0
LOUIS LUCIDO
DIRECTOR1.00Yes (X)$0$0$0
MOLLY MCCABE
DIRECTOR1.00Yes (X)$0$0$0
NADEEM MEGHJI
DIRECTOR1.00Yes (X)$0$0$0
WILLIAM J MULVIHILL
DIRECTOR1.00Yes (X)$0$0$0
ROBERT SEDER MD
DIRECTOR1.00Yes (X)$0$0$0
DANIEL J WALLACE
DIRECTOR1.00Yes (X)$0$0$0
WILLIAM WOLFE
DIRECTOR1.00Yes (X)$0$0$0
CAROL WEISMAN
DIRECTOR1.00Yes (X)$0$0$0
SPENCER ZWICK
DIRECTOR1.00Yes (X)$0$0$0
KENNETH M FARBER
CEO AND PRESIDENT40.00Yes (X)$416,526$0$72,766
DEBRA ROSE
CHIEF FINANCE OFFICER40.00Yes (X)$195,821$0$42,642
ANDREA O'NEILL
EXECUTIVE DIRECTOR40.00$246,253$0$47,078Yes (X)
ALBERT ROY
EXECUTIVE DIRECTOR, LUCIN40.00$261,724$0$62,741Yes (X)
TEODORA STAEVA
CHIEF SCIENTIFIC OFFICER40.00$285,631$0$57,047Yes (X)
DIANE GROSS
NATIONAL DIRECTOR OF ADVOC40.00$130,289$0$35,290Yes (X)
MARGY MEISLIN
EDITORIAL & PR DIRECTOR40.00$127,882$0$37,177Yes (X)
DOREY NEILINGER
SENIOR DIRECTOR OF PHILANT40.00$165,082$0$34,323Yes (X)
DENISE PRIOR
DIRECTOR OF COMMUNICATIONS40.00$136,357$0$19,731Yes (X)
JONATHAN MARKS
DIRECTOR OF CORPORATE40.00$139,123$0$62,475Yes (X)
MARGARET P DOWD
FORMER CO-CEO AND CO-PRESIDENT40.00$203,823$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,308,511TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$471,270TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K11IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (1)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (4 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
AMPEL BIOSOLUTIONS LLC
250 WEST MAIN STREET SUITE 300CHARLOTTESVILLEVA22902LUCIN CLINICAL TRIALS$325,051
KIM KAISER & ASSOCIATES LLC
151 CENTRE AVE 1ANEW ROCHELLENY10805PHARMA RELATIONS CONSULTANT$265,585
KDH RESEACH AND COMMUNICATION INC
1175 PEACH TREE STREET NEATLANTAGA30361PATIENT ENGAGEMENT CONSULTANTS$140,479
CAVAROCCHI RUSCIA DENNIS & ASSOCIATES LL
600 MARLAND AVE SW SUITE 835 WWASHINGTONDC20024PUBLIC POLICY CONSULTANTS$102,027
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K4CntrctRcvdGreaterThan100KCnt
Fundraising$5,355,038FundraisingAmt
All Other Contributions$12,318,584AllOtherContributionsAmt
Noncash Contributions$607,005NoncashContributionsAmt
Total Contributions$17,673,622TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescLUCIN CONSULTING REVENUEDesc
Business900099BusinessCd
Total Revenue Column$1,236,449TotalRevenueColumnAmt
Related Or Exempt Func Income$1,236,449RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$1,236,449TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,445,946TotalRevenueColumnAmt
Exclusion$1,445,946ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$9,522,480SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$8,819,805SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$702,675SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$702,675TotalRevenueColumnAmt
Exclusion$702,675ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$516,170FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$5,355,038ContriRptFundraisingEventAmt
Fundraising Direct Expenses$516,170FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$21,058,692TotalRevenueColumnAmt
Related Or Exempt Func Income$1,236,449RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$2,148,621ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$13,609,455TotalAmt
Program Services$13,609,455ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$1,828TotalAmt
Program Services$1,828ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$1,894,265TotalAmt
Program Services$1,894,265ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,612,177TotalAmt
Program Services$778,927ProgramServicesAmt
Management And General$361,217ManagementAndGeneralAmt
Fundraising$472,033FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$2,615,038TotalAmt
Program Services$1,114,639ProgramServicesAmt
Management And General$603,948ManagementAndGeneralAmt
Fundraising$896,451FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$177,941TotalAmt
Program Services$75,962ProgramServicesAmt
Management And General$38,809ManagementAndGeneralAmt
Fundraising$63,170FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$502,236TotalAmt
Program Services$217,956ProgramServicesAmt
Management And General$115,605ManagementAndGeneralAmt
Fundraising$168,675FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$265,543TotalAmt
Program Services$118,367ProgramServicesAmt
Management And General$60,581ManagementAndGeneralAmt
Fundraising$86,595FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$150,000TotalAmt
Program Services$150,000ProgramServicesAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$79,683TotalAmt
Program Services$73,312ProgramServicesAmt
Management And General$5,396ManagementAndGeneralAmt
Fundraising$975FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$65,399TotalAmt
Management And General$65,399ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$104,186TotalAmt
Program Services$104,186ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$49,000TotalAmt
Fundraising$49,000FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$122,792TotalAmt
Management And General$122,792ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,041,750TotalAmt
Program Services$705,958ProgramServicesAmt
Management And General$156,176ManagementAndGeneralAmt
Fundraising$179,616FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$115,567TotalAmt
Program Services$43,339ProgramServicesAmt
Management And General$54,124ManagementAndGeneralAmt
Fundraising$18,104FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$514,570TotalAmt
Program Services$255,833ProgramServicesAmt
Management And General$198,927ManagementAndGeneralAmt
Fundraising$59,810FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,087,395TotalAmt
Program Services$549,844ProgramServicesAmt
Management And General$221,269ManagementAndGeneralAmt
Fundraising$316,282FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$440,447TotalAmt
Program Services$292,646ProgramServicesAmt
Management And General$47,496ManagementAndGeneralAmt
Fundraising$100,305FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$829,731TotalAmt
Program Services$751,222ProgramServicesAmt
Management And General$62,651ManagementAndGeneralAmt
Fundraising$15,858FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$172,125TotalAmt
Program Services$76,726ProgramServicesAmt
Management And General$39,269ManagementAndGeneralAmt
Fundraising$56,130FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$63,877TotalAmt
Program Services$39,018ProgramServicesAmt
Management And General$10,233ManagementAndGeneralAmt
Fundraising$14,626FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
CLINICAL STUDIES$512,086$512,086
PRINTING & PUBLICATIONS$229,776$48,773$27,194$153,809
WALKATHON PROMOTIONAL E$216,339$216,339
DATA PROCESSING$106,851$27,331$18,926$60,594

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$230,985TotalAmt
Program Services$87,712ProgramServicesAmt
Management And General$42,057ManagementAndGeneralAmt
Fundraising$101,216FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$26,811,042TotalAmt
Program Services$21,529,385ProgramServicesAmt
Management And General$2,252,069ManagementAndGeneralAmt
Fundraising$3,029,588FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$4,086,022BOYAmt
EOY$3,724,504EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,120,958BOYAmt
EOY$873,961EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$4,778,785BOYAmt
EOY$2,579,649EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$157,680BOYAmt
EOY$373,770EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$168,860BOYAmt
EOY$162,892EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$1,097,598LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$603,119LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$573,771BOYAmt
EOY$494,479EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$52,069,569BOYAmt
EOY$61,719,649EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$1,514,965BOYAmt
EOY$398,731EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$609,345BOYAmt
EOY$1,104,083EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$65,079,955BOYAmt
EOY$71,431,718EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$465,895BOYAmt
EOY$438,885EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$22,572,203BOYAmt
EOY$25,422,502EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$780,561BOYAmt
EOY$800,130EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$23,818,659BOYAmt
EOY$26,661,517EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$36,803,806BOYAmt
EOY$39,293,680EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$4,457,490BOYAmt
EOY$5,476,521EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$41,261,296BOYAmt
EOY$44,770,201EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$65,079,955BOYAmt
EOY$71,431,718EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$5,752,350ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$7,845,756NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$1,415,499OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$15,274,909CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$19,101,537CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$23,693,133CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$15,396,535CurrentTaxYearMinus1YearAmt
Current Tax Year$17,673,622CurrentTaxYearAmt
Total$91,139,736TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$15,274,909CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$19,101,537CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$23,693,133CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$15,396,535CurrentTaxYearMinus1YearAmt
Current Tax Year$17,673,622CurrentTaxYearAmt
Total$91,139,736TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$33,190,250SubstantialContributorsTotAmt
Public Support Total170$57,949,486PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,817,934CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,227,336CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,314,981CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,336,303CurrentTaxYearMinus1YearAmt
Current Tax Year$1,445,946CurrentTaxYearAmt
Total$7,142,500TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$118CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years-$440CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$204CurrentTaxYearMinus2YearsAmt
Total-$118TotalAmt
FieldValueIRS element (for citing)
Total Support$98,282,118TotalSupportAmt
Gross Receipts Rltd Activities$2,815,330GrossReceiptsRltdActivitiesAmt
Public Support CY1700.58960PublicSupportCY170Pct
Public Support PY1700.56890PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$846,235FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$846,235FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$25,964,807FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$26,811,042FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,000,000FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$250,000FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,000,000CurrentYearMinus3Amt
Current Year Minus2$1,000,000CurrentYearMinus2Amt
Current Year Minus1$1,000,000CurrentYearMinus1Amt
Current Year$1,000,000CurrentYearAmt
Total$4,000,000TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$541,256CurrentYearMinus3Amt
Current Year Minus2$776,350CurrentYearMinus2Amt
Current Year Minus1$788,377CurrentYearMinus1Amt
Current Year$846,235CurrentYearAmt
Total$2,952,218TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$250,000CurrentYearMinus3Amt
Current Year Minus2$250,000CurrentYearMinus2Amt
Current Year Minus1$250,000CurrentYearMinus1Amt
Current Year$250,000CurrentYearAmt
Total$1,000,000TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$46,122,925BeginningYearBalanceAmt
Investment Earnings Or Losses$8,404,231InvestmentEarningsOrLossesAmt
Other Expenditures$2,713,456OtherExpendituresAmt
End Year Balance$51,813,456EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$51,742,397BeginningYearBalanceAmt
Investment Earnings Or Losses-$2,936,193InvestmentEarningsOrLossesAmt
Other Expenditures$2,683,279OtherExpendituresAmt
End Year Balance$46,122,925EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$45,863,827BeginningYearBalanceAmt
Investment Earnings Or Losses$8,478,913InvestmentEarningsOrLossesAmt
Other Expenditures$2,600,343OtherExpendituresAmt
End Year Balance$51,742,397EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$44,173,045BeginningYearBalanceAmt
Investment Earnings Or Losses$4,257,605InvestmentEarningsOrLossesAmt
Other Expenditures$2,566,823OtherExpendituresAmt
End Year Balance$45,863,827EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$48,100,254BeginningYearBalanceAmt
Investment Earnings Or Losses-$1,498,278InvestmentEarningsOrLossesAmt
Other Expenditures$2,428,931OtherExpendituresAmt
End Year Balance$44,173,045EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY1.00000BoardDesignatedBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$424,912OtherCostOrOtherBasisAmt
Depreciation$141,550DepreciationAmt
Book Value$283,362BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$672,686OtherCostOrOtherBasisAmt
Depreciation$461,569DepreciationAmt
Book Value$211,117BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$494,479TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDEFERRED RENTDesc
Amt$800,130Amt
FieldValueIRS element (for citing)
Total Liability$800,130TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$30,031,656TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$7,845,756NetUnrealizedGainsInvstAmt
Recoveries Prior Year Grants$1,250,000RecoveriesPriorYearGrantsAmt
Revenue Not Reported$9,095,756RevenueNotReportedAmt
Revenue Subtotal$20,935,900RevenueSubtotalAmt
Investment Expenses Not Incld$122,792InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$122,792RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$21,058,692TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$26,522,751TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$26,522,751ExpensesSubtotalAmt
Investment Expenses Not Incld2$122,792InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$165,499OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$288,291ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$26,811,042TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4:BOARD DESIGNATED (QUASI) ENDOWMENT FUND INCOME TO BE USED FOR RESEARCH PROGRAM GRANTS. PRINCIPAL TO REMAIN INTACT UNLESS HIGH PRIORITY LUPUS RESEARCH PROJECTS NEED TO BE FUNDED THAT COULD NOT BE FUNDED OTHERWISE.
PART XII, LINE 4B - OTHER ADJUSTMENTS:RETURN OF GRANTS & ADJUSTMENTS 165,499.
PART PART XII, LINE 4BUNUSED PORTIONS OF GRANTS RETURNED TO LRA THAT WERE PAID IN PREVIOUS YEARS IN THE AMOUNT OF $5,499. THESE AMOUNTS ARE RECONCILING ITEMS BETWEEN THE REVENUE AND EXPENSES FROM THE AUDITED FINANCIAL STATEMENTS AND THOSE REPORTED ON FORM 990.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFIC00GRANTS TO RECIPIENTS$1,254,265
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES00GRANTS TO RECIPIENTS$640,000
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$1,894,265SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$1,894,265TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (10 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtValuation Method UsedValuationMethodUsedDesc
NORTH AMERICALUPUS RESEARCH$80,000CHECKBOOK
NORTH AMERICALUPUS RESEARCH$80,000CHECKBOOK
NORTH AMERICALUPUS RESEARCH$80,000CHECKBOOK
NORTH AMERICALUPUS RESEARCH$80,000CHECKBOOK
NORTH AMERICALUPUS RESEARCH$80,000CHECKBOOK
NORTH AMERICALUPUS RESEARCH$80,000CHECKBOOK
NORTH AMERICALUPUS RESEARCH$80,000CHECKBOOK
NORTH AMERICALUPUS RESEARCH$80,000CHECKBOOK
EAST ASIA AND THE PACIFICLUPUS RESEARCH$307,535CHECKBOOK
EAST ASIA AND THE PACIFICLUPUS RESEARCH$946,730CHECKBOOK
FieldValueIRS element (for citing)
Total501c3 Org5Total501c3OrgCnt
Total Other Org5TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:PRE AWARD AND APPLICATION PHASE: BEFORE A GRANT IS AWARDED, THE SPONSORING INSTITUTION (SI) MUST AGREE TO THE TERMS AND CONDITIONS OUTLINED IN THE LUPUS RESEARCH ALLIANCE (LRA)'S POLICY STATEMENT FOR RESEARCH GRANTS THAT INCLUDE: -CONFIRMATION BY THE PRINCIPAL INVESTIGATOR (PI) AND THE SI THAT FUNDS WILL ONLY BE USED AS DESCRIBED IN THE APPLICATION SUBMITTED AND APPROVED FOR FUNDING. -AGREE THAT PI AND SI ARE BOTH RESPONSIBLE FOR INSURING THAT ALL RESEARCH ACTIVITIES ARE CONDUCTED IN A SAFE, RESPONSIBLE AND ETHICAL MANNER. THEY MUST KEEP UPDATED APPROVAL FROM THE SI'S INSTITUTIONAL REVIEW BOARD AND ANIMAL CARE AND USE COMMITTEE THOUGHT OUT THE PROJECT PERIOD. -AGREE TO GET APPROVAL FROM THE LRA IF THERE NEEDS TO BE A SIGNIFICANT CHANGE TO THE BUDGET AS SUBMITTED. -AGREE TO GET APPROVAL FROM THE LRA IF ADDITIONAL TIME IS NEEDED TO COMPLETE THE PROJECT WORK. -AGREE TO SUBMIT ALL DELIVERABLES AND REPORTS AS SCHEDULED: (A) ANNUAL PROGRESS REPORTS AND (B) ANNUAL FINANCIAL REPORTS ARE REQUIRED. -TRAVEL FUNDS PROVIDED AS PART OF THE PROJECT ARE EXPECTED TO BE USED TO ATTEND THE LRA'S ANNUAL MEETING FORUM FOR DISCOVERY. -CONFIRMATION THAT THERE IS NO OTHER ACTIVE OF PENDING SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THE GRANT. POST AWARD: THE PI AND A REPRESENTATIVE FROM THE SI MUST SUBMIT: A SIGNED LETTER OF ACCEPTANCE CONFIRMING THE FOLLOWING: A. PI'S WILLINGNESS TO ADHERE TO THE TERMS OF THE BUDGET AS OUTLINED IN THE FUNDING LETTER. B. PI'S WILLINGNESS TO COMPLY WITH ALL OF THE CONDITIONS OUTLINED IN THE POLICY STATEMENT FOR RESEARCH GRANTS AND PATENT AND INTELLECTUAL PROPERTY POLICY. C. THERE IS NO OVERLAPPING SOURCE OF SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THIS GRANT. OTHER FUNDING THAT MIGHT BE CONSTRUED AS OVERLAPPING, MUST BE EXPLAINED IN DETAIL. D. THE FOLLOWING STATEMENT SHOULD APPEAR AT THE CONCLUSION OF THE LETTER OF ACCEPTANCE, "I AGREE TO ACCEPT RESPONSIBILITY FOR THE SCIENTIFIC AND TECHNICAL CONDUCT OF THE RESEARCH PROJECT AND FOR THE PROVISION OF ALL PROGRESS REPORTS REQUIRED FROM INVESTIGATORS FUNDED BY A GRANT FROM THE LUPUS RESEARCH ALLIANCE." -IF AN EXTENSION IS AWARDED ADDITIONAL INTERIM PROGRESS REPORTS AND BUDGET RECONCILIATIONS ARE REQUIRED TO BE SUBMITTED. -AT THE END OF THE GRANT A FINAL PROGRESS REPORT AND BUDGET RECONCILIATION IS REQUIRED TO BE SUBMITTED, UNSPENT AMOUNTS ARE TO BE RETURNED TO THE LRA. -ALL SIS RECEIVE A PAYMENT AND DELIVERABLE SCHEDULE AND THE PROJECT IS MONITORED BY: O PERIODIC PROGRESS REPORTS O PERIODIC BUDGET RECONCILIATIONS -ALL PUBLICATIONS RELATED TO THE GRANT ARE TO BE SUBMITTED TO THE LRA -THE LRA MUST BE LISTED AS A FUNDER IN ANY PUBLISHED PAPERS AND VERBAL OR POSTER PRESENTATIONS -THE SI MUST SUBMIT A COPY OF THE IRS OR OTHER TAX GOVERNING INSTITUTION CONFIRMING THE TAX STATUS OF THE SI
PART III ACCOUNTING METHOD:

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (1)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Organization Business Name OrganizationBusinessName

FieldValueIRS element (for citing)
Business Name Line1DS CONSULTING GROUPBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1845 THIRD AVENUE 6TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10022ZIPCd
FieldValueIRS element (for citing)
ActivitySPECIAL EVENT CONSULTANT NY GALAActivityTxt
Fundraiser Control Of FundsYes (1)FundraiserControlOfFundsInd
Gross Receipts$2,982,628GrossReceiptsAmt
Retained By Contractor$49,000RetainedByContractorAmt
Net To Organization$2,982,628NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Gross Receipts$2,982,628TotalGrossReceiptsAmt
Total Retained By Contractors$49,000TotalRetainedByContractorsAmt
Total Net To Organization$2,982,628TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDELicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesIDLicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesIALicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesMTLicensedStatesCd
Licensed StatesNELicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesSDLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesVTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1GALA CELEBRATIONEvent1Nm
Gross Receipts Event1$2,982,628GrossReceiptsEvent1Amt
Charitable Contri Event1$2,654,211CharitableContriEvent1Amt
Gross Revenue Event1$328,417GrossRevenueEvent1Amt
Food And Beverage Event1$181,157FoodAndBeverageEvent1Amt
Other Direct Expenses Event1$147,260OtherDirectExpensesEvent1Amt
Event2WALK-A-THONSEvent2Nm
Gross Receipts Event2$1,361,711GrossReceiptsEvent2Amt
Charitable Contri Event2$1,331,735CharitableContriEvent2Amt
Gross Revenue Event2$29,976GrossRevenueEvent2Amt
Other Direct Expenses Event2$29,976OtherDirectExpensesEvent2Amt
Other Events Total2OtherEventsTotalCnt
Gross Receipts Other Events$1,526,869GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$1,369,092CharitableContriOtherEventsAmt
Gross Revenue Other Events$157,777GrossRevenueOtherEventsAmt
Oth Direct Expnss Other Events$157,777OthDirectExpnssOtherEventsAmt
Gross Receipts Total$5,871,208GrossReceiptsTotalAmt
Charitable Contributions Tot$5,355,038CharitableContributionsTotAmt
Gross Revenue Total Events$516,170GrossRevenueTotalEventsAmt
Food And Beverage Total Events$181,157FoodAndBeverageTotalEventsAmt
Oth Direct Expnss Total Events$335,013OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$516,170DirectExpenseSummaryEventsAmt
Net Income Summary$0NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE G, PART I, LINE 2B, COLUMN (V)FormAndLineReferenceDesc
ExplanationDS CONSULTING PLANNED AND MANAGED ALR'S GALA EVENT. CONTRACT AMOUNT FOR THE PERIOD COVERING 1/1/19 - 12/31/19 WAS $49,000 PLUS REIMBURSABLE EXPENSES.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (55 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtValuation Method UsedValuationMethodUsedDescPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVEBRONXNY10461472209056501(C)(3)$80,000BOOKLUPUS RESEARCH
BETH ISRAEL DEACONESS MEDICAL CENTER
330 BROOKLINE AVENUEBOSTONMA02215042103881501(C)(3)$80,000BOOKLUPUS RESEARCH
BRIGHAM AND WOMEN'S HOSPITAL
77 AVENUE LOUIS PASTEURBOSTONMA02115042312909501(C)(3)$777,449BOOKLUPUS RESEARCH
BROAD INSTITUTE INC
SEVEN CAMBRIDGE CENTERCAMBRIDGEMA02142263428781501(C)(3)$13,470BOOKLUPUS RESEARCH
CHILDREN'S HOSPITAL BOSTON
300 LONGWOOD AVENUEBOSTONMA02115042774441501(C)(3)$195,640BOOKLUPUS RESEARCH
COLUMBIA UNIVERSITY MEDICAL CENTER
154 HAVEN AVE 2ND FLNEW YORKNY10032133598093501(C)(3)$122,514BOOKLUPUS RESEARCH
EMORY UNIVERSITY
1762 CLIFTON RD NEATLANTAGA30322580566256501(C)(3)$246,000BOOKLUPUS RESEARCH
HOSPITAL FOR SPECIAL SURGERY
535 E 70TH STREETNEW YORKNY10021131624135501(C)(3)$104,952BOOKLUPUS RESEARCH
LOYOLA UNIVERSITY OF CHICAGO
820 N MICHIGAN AVECHICAGOIL60611361408475501(C)(3)$300,000BOOKLUPUS RESEARCH
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA02114042697983501(C)(3)$80,000BOOKLUPUS RESEARCH
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905416011702501(C)(3)$80,000BOOKLUPUS RESEARCH
MEDICAL UNIVERSITY OF SOUTH CAROLINA
179 ASHLEY AVENUECHARLESTONSC29425576028985SECTION 115 - SC STA$90,381BOOKLUPUS RESEARCH
NATIONAL MINORITY QUALITY FORUM INC
1201 15TH STREET NW SUITE 340WASHINGTONDC20005311750942501(C)(3)$379,800BOOKLUPUS RESEARCH
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
550 FIRST AVENUENEW YORKNY10016135562308501(C)(3)$100,183BOOKLUPUS RESEARCH
NORTHWELL HEALTH - DIVISION OF RHEUMATOLOGY
972 BRUSH HOLLOW RD 5TH FLWESTBURYNY11590112673595501(C)(3)$80,000BOOKLUPUS RESEARCH
NORTHWESTERN UNIVERSITY
633 CLARK STREETEVANSTONIL60208362167818501(C)(3)$380,000BOOKLUPUS RESEARCH
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13TH STREETOKLAHOMA CITYOK73104730580274501(C)(3)$380,000BOOKLUPUS RESEARCH
PENNSYLVANIA STATE UNIVERSITY
ONE OLD MAINUNIVERSITY PARKPA16802246000376501(C)(3)$96,613BOOKLUPUS RESEARCH
REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE
5171 CALIFORNIA AVENUE STE 150IRVINECA92697952226406501(C)(3)$80,000BOOKLUPUS RESEARCH
RUSH UNIVERSITY MEDICAL CENTER
1653 WEST CONGRESS PARKWAYCHICAGOIL60612362174823501(C)(3)$80,000BOOKLUPUS RESEARCH
ST JUDE CHILDREN'S HOSPITAL
262 DANNY THOMAS PLMEMPHISTN38105620646012501(C)(3)$580,158BOOKLUPUS RESEARCH
STANFORD UNIVERSITY
3145 PORTER DRIVEPALO ALTOCA94304941156365501(C)(3)$80,000BOOKLUPUS RESEARCH
TEMPLE UNIVERSITY
1801 N BROAD STREETPHILADELPHIAPA19122231365971501(C)(3)$90,616BOOKLUPUS RESEARCH
THE CENTER FOR INFORMATION & STUDY ON CLINICAL RESARCH PARTICPATION
56 COMMERCIAL WHARF EASTBOSTONMA02110200588190501(C)(3)$5,000BOOKLUPUS RESEARCH
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
350 COMMUNITY DRIVEMANHASSETNY11030112673595501(C)(3)$3,107,722BOOKLUPUS RESEARCH
THE METROHEALTH SYSTEM
2500 METROHEALTH DRIVECLEVELANDOH44109346004382SECTION 115 - OH STA$80,000BOOKLUPUS RESEARCH
THE OHIO STATE UNIVERSITY
1960 KENNY ROADCOLUMBUSOH43210311702164SECTION 115 - OH STA$80,000BOOKLUPUS RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES
10920 WILSHIRE BLVD STE 620LOS ANGELESCA90024956006143501(C)(3)$179,446BOOKLUPUS RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE MC0934LA JOLLACA92093956006144501(C)(3)$105,000BOOKLUPUS RESEARCH
THE RESEARCH FOUNDATION OF SUNY
35 STATE STREETALBANYNY12201141368361501(C)(3)$80,000BOOKLUPUS RESEARCH
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUE STE 501CHICAGOIL60637362177139501(C)(3)$80,000BOOKLUPUS RESEARCH
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
6000 FELDWOOD ROADCOLLEGE PARKGA30349566001393501(C)(3)$183,334BOOKLUPUS RESEARCH
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREETPHILADELPHIAPA19104231352685501(C)(3)$637,993BOOKLUPUS RESEARCH
UNIVERISTY OF SOUTHERN CALIFORNIA
1640 MARENGO STREET 7TH FLLOS ANGELESCA90033951642394501(C)(3)$90,377BOOKLUPUS RESEARCH
UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE SBIRMINGHAMAL35294636005396501(C)(3)$672,197BOOKLUPUS RESEARCH
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
2200 UNIVERSITY HALLBERKELEYCA94720946036493501(C)(3)$88,932BOOKLUPUS RESEARCH
UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS
3100 MARINE ST 6TH FLBOULDERCO80309846000555501(C)(3)$80,000BOOKLUPUS RESEARCH
UNIVERSITY OF FLORIDA
207 TIGERT HALLGAINESVILLEFL32611596002052FL STATE GOVERNMENT$86,020BOOKLUPUS RESEARCH
UNIVERSITY OF HOUSTON
4800 CALHOUN ROADHOUSTONTX77004746001399501(C)(3)$10,312BOOKLUPUS RESEARCH
UNIVERSITY OF MARYLAND BALTIMORE
620 W LEXINGON STREET 4TH FLBALTIMOREMD21201521830242SECTION 115 - MD STA$80,000BOOKLUPUS RESEARCH
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655043167325MA STATE GOVERNMENT$96,742BOOKLUPUS RESEARCH
UNIVERSITY OF MIAMI
1320 S DIXIE HIGHWAY GABLES ONECORAL GABLESFL33146590624458501(C)(3)$80,000BOOKLUPUS RESEARCHTOWER 650
UNIVERSITY OF MICHIGAN
503 THOMPSON STREETANN ARBORMI48109386006309501(C)(3)$972,198BOOKLUPUS RESEARCH
UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
2500 NORTH STATE STREETJACKSONMS39216646008520501(C)(3)$90,000BOOKLUPUS RESEARCH
UNIVERSITY OF NEBRASKA
987835 NEBRASKA MEDICAL CENTEROMAHANE68198470049123501(C)(3)$8,932BOOKLUPUS RESEARCH
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH
3500 CAMP BOWIE BLVDFORT WORTHTX76107710986983501(C)(3)$6,020BOOKLUPUS RESEARCH
UNIVERSITY OF PITTSBURGH
123 UNIVERSITY PLACEPITTSBURGHPA15213250965591501(C)(3)$97,864BOOKLUPUS RESEARCH
UNIVERSITY OF ROCHESTER
518 HYLAN BUILDINGROCHESTERNY14627160743209501(C)(3)$80,000BOOKLUPUS RESEARCH
UNIVERSITY OF WASHINGTON
3917 UNIVERSITY WAY NESEATTLEWA98195916001537SECTION 115 - WA STA$86,713BOOKLUPUS RESEARCH
UT SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVDDALLASTX75390746000203TX STATE GOVERNMENT$86,567BOOKLUPUS RESEARCH
VANDERBILT UNIVERSITY MEDICAL CENTER
1211 MEDICAL CENTER DRIVENASHVILLETN37232352528741501(C)(3)$1,026,730BOOKLUPUS RESEARCH
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BLVDWINSTONSALEMNC27157223849199501(C)(3)$80,000BOOKLUPUS RESEARCH
WALLACE RHEUMATIC STUDIES CENTER LLC
8737 BENVERLY BLVD STE 301W HOLLYWOODCA90048455434561501(C)(3)$80,000BOOKLUPUS RESEARCH
YAEL UNIVERSITY
BOX 208239NEW HAVENCT06520060646973501(C)(3)$93,425BOOKLUPUS RESEARCH
UNIVERSITY OF TEXAS AT SAN ANTONIO
7703 FLOYS CURL DRIVESAN ANTONIOTX782293900746000203TX STATE GOVERNMENT$580,155BOOKLUPUS RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org46Total501c3OrgCnt
Total Other Org9TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationPRE AWARD AND APPLICATION PHASE: BEFORE A GRANT IS AWARDED, THE SPONSORING INSTITUTION (SI) MUST AGREE TO THE TERMS AND CONDITIONS OUTLINED IN THE LUPUS RESEARCH ALLIANCE (LRA)'S POLICY STATEMENT FOR RESEARCH GRANTS THAT INCLUDE: -CONFIRMATION BY THE PRINCIPAL INVESTIGATOR (PI) AND THE SI THAT FUNDS WILL ONLY BE USED AS DESCRIBED IN THE APPLICATION SUBMITTED AND APPROVED FOR FUNDING. -AGREE THAT PI AND SI ARE BOTH RESPONSIBLE FOR INSURING THAT ALL RESEARCH ACTIVITIES ARE CONDUCTED IN A SAFE, RESPONSIBLE AND ETHICAL MANNER. THEY MUST KEEP UPDATED APPROVAL FROM THE SI'S INSTITUTIONAL REVIEW BOARD AND ANIMAL CARE AND USE COMMITTEE THOUGHT OUT THE PROJECT PERIOD. -AGREE TO GET APPROVAL FROM THE LRA IF THERE NEEDS TO BE A SIGNIFICANT CHANGE TO THE BUDGET AS SUBMITTED. -AGREE TO GET APPROVAL FROM THE LRA IF ADDITIONAL TIME IS NEEDED TO COMPLETE THE PROJECT WORK. -AGREE TO SUBMIT ALL DELIVERABLES AND REPORTS AS SCHEDULED: (A) ANNUAL PROGRESS REPORTS AND (B) ANNUAL FINANCIAL REPORTS ARE REQUIRED. -TRAVEL FUNDS PROVIDED AS PART OF THE PROJECT ARE EXPECTED TO BE USED TO ATTEND THE LRA'S ANNUAL MEETING FORUM FOR DISCOVERY. -CONFIRMATION THAT THERE IS NO OTHER ACTIVE OF PENDING SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THE GRANT. POST AWARD: THE PI AND A REPRESENTATIVE FROM THE SI MUST SUBMIT: A SIGNED LETTER OF ACCEPTANCE CONFIRMING THE FOLLOWING: A. PI'S WILLINGNESS TO ADHERE TO THE TERMS OF THE BUDGET AS OUTLINED IN THE FUNDING LETTER. B. PI'S WILLINGNESS TO COMPLY WITH ALL OF THE CONDITIONS OUTLINED IN THE POLICY STATEMENT FOR RESEARCH GRANTS AND PATENT AND INTELLECTUAL PROPERTY POLICY. C. THERE IS NO OVERLAPPING SOURCE OF SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THIS GRANT. OTHER FUNDING THAT MIGHT BE CONSTRUED AS OVERLAPPING, MUST BE EXPLAINED IN DETAIL. D. THE FOLLOWING STATEMENT SHOULD APPEAR AT THE CONCLUSION OF THE LETTER OF ACCEPTANCE, "I AGREE TO ACCEPT RESPONSIBILITY FOR THE SCIENTIFIC AND TECHNICAL CONDUCT OF THE RESEARCH PROJECT AND FOR THE PROVISION OF ALL PROGRESS REPORTS REQUIRED FROM INVESTIGATORS FUNDED BY A GRANT FROM THE LUPUS RESEARCH ALLIANCE." -IF AN EXTENSION IS AWARDED ADDITIONAL INTERIM PROGRESS REPORTS AND BUDGET RECONCILIATIONS ARE REQUIRED TO BE SUBMITTED. -AT THE END OF THE GRANT A FINAL PROGRESS REPORT AND BUDGET RECONCILIATION IS REQUIRED TO BE SUBMITTED, UNSPENT AMOUNTS ARE TO BE RETURNED TO THE LRA. -ALL SIS RECEIVE A PAYMENT AND DELIVERABLE SCHEDULE AND THE PROJECT IS MONITORED BY: 1 PERIODIC PROGRESS REPORTS 2 PERIODIC BUDGET RECONCILIATIONS -ALL PUBLICATIONS RELATED TO THE GRANT ARE TO BE SUBMITTED TO THE LRA -THE LRA MUST BE LISTED AS A FUNDER IN ANY PUBLISHED PAPERS AND VERBAL OR POSTER PRESENTATIONS -THE SI MUST SUBMIT A COPY OF THE IRS OR OTHER TAX GOVERNING INSTITUTION CONFIRMING THE TAX STATUS OF THE SIExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (1)SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
KENNETH M FARBER
CEO AND PRESIDENT$360,000$0$50,000$0$6,526$0$28,000$0$44,766$0$489,292$0$0$0
DEBRA ROSE
CHIEF FINANCE OFFICER$178,605$0$15,000$0$2,216$0$21,047$0$21,595$0$238,463$0$0$0
ANDREA O'NEILL
EXECUTIVE DIRECTOR$204,750$0$40,000$0$1,503$0$26,733$0$20,345$0$293,331$0$0$0
ALBERT ROY
EXECUTIVE DIRECTOR, LUCIN$220,752$0$40,000$0$972$0$20,860$0$41,881$0$324,465$0$0$0
TEODORA STAEVA
CHIEF SCIENTIFIC OFFICER$244,359$0$40,000$0$1,272$0$22,749$0$34,298$0$342,678$0$0$0
DIANE GROSS
NATIONAL DIRECTOR OF ADVOC$127,435$0$2,000$0$854$0$13,420$0$21,870$0$165,579$0$0$0
MARGY MEISLIN
EDITORIAL & PR DIRECTOR$125,000$0$1,000$0$1,882$0$12,600$0$24,577$0$165,059$0$0$0
DOREY NEILINGER
SENIOR DIRECTOR OF PHILANT$161,029$0$0$0$4,053$0$17,713$0$16,610$0$199,405$0$0$0
DENISE PRIOR
DIRECTOR OF COMMUNICATIONS$69,436$0$0$0$66,921$0$2,381$0$17,350$0$156,088$0$0$0
JONATHAN MARKS
DIRECTOR OF CORPORATE$135,403$0$3,000$0$720$0$15,224$0$47,251$0$201,598$0$0$0
MARGARET P DOWD
FORMER CO-CEO AND CO-PRESIDENT$203,823$0$0$0$0$0$0$0$0$0$203,823$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 4AFormAndLineReferenceDesc
ExplanationDENISE PRIOR, HIGHLY COMPENSATED EMPLOYEE, RECIEVED $59,517 SEVERANCE PAYMENT IN 2019.ExplanationTxt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution7ContributionCnt
Noncash Contributions Rpt F990$113,505NoncashContributionsRptF990Amt
Method Of Determining RevenuesAVG STOCK VALUEMethodOfDeterminingRevenuesTxt

Real Estate Residential RealEstateResidentialGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution1ContributionCnt
Noncash Contributions Rpt F990$493,500NoncashContributionsRptF990Amt
Method Of Determining RevenuesAPPRAISED VALUEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties UsedYes (1)ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 32B:FormAndLineReferenceDesc
ExplanationLRA HAS AN ACCOUNT WITH MORGAN STANLEY, WHICH LRA USES TO SELL THE CONTRIBUTIONS IT RECEIVES THOUGH STOCKS. LRA HIRED AN AGENT TO SELL A PROPERTY THAT WAS DONATED TO LRAExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 2NEIL J. BURMEISTER (DIRECTOR) AND IRA AKSELRAD (DIRECTOR) HAVE A BUSINESS RELATIONSHIP. RICHARD K. DESCHERER (CO-CHAIR) AND JENNIE DESCHERER HAVE A FAMILY RELATIONSHIP.
FORM 990, PART VI, SECTION B, LINE 11BAFTER PREPARATION BY OF FORM 990 BY LRA'S AUDITOR, LUTZ AND CARR, THE 990 IS REVIEWED BY THE LRA'S SENIOR OFFICERS, THE CHIEF FINANCE OFFICER AND THE PRESIDENT. THE FINANCE AND AUDIT COMMITTEE OF THE BOARD THEN MEETS TO REVIEW THE 990 BEFORE FILING AND APPROVES FOR FILING WITH ANY NOTED CHANGES. A DRAFT OF THE 990 IS THEN SENT OUT TO THE FULL BOARD FOR COMMENT PRIOR TO FILING WITH THE IRS. THE FINAL FORM 990 IS PRESENTED TO THE FULL BOARD AT THE SEPTEMBER MEETING.
FORM 990, PART VI, SECTION B, LINE 12CTHE GOVERNANCE COMMITTEE OF THE BOARD IS RESPONSIBLE FOR MONITORING CONFLICTS OF INTEREST. AN ANNUAL CONFLICT OF INTEREST DISCLOSURE FORM IS REQUIRED TO BE FILLED OUT EACH YEAR BY BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES.
FORM 990, PART VI, SECTION B, LINE 15THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTED THE BOARD IN FULFILLING ITS OVERSIGHT RESPONSIBILITIES RELATING TO THE COMPENSATION AND BENEFITS OF THE PRESIDENT AND OTHER EXECUTIVE OFFICERS; AND PROVIDED RECOMMENDATIONS REGARDING MANAGEMENT SUCCESSORS. ANNUALLY THE COMMITTEE REVIEWS AND RECOMMENDS TO THE BOARD THE SALARY FOR THE PRESIDENT AND OTHER OFFICERS/KEY EMPLOYEES. IN 2018, THE COMMITTEE REVIEWED AND APPROVED BASE SALARIES, ANNUAL MERIT ADJUSTMENTS AND BONUSES FOR ALL STAFF.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST AND ON GUIDESTAR.ORG
FORM 990, PART XI, LINE 9:REFUND OF GRANTS 165,499. CANCELLED GRANTS 1,250,000.
FORM 990, PART V, QUESTION 2ATHE LRA CONTRACTS WITH TRINET AMBROSE, A PROFESSIONAL EMPLOYER ORGANIZATION (PEO), TO PROVIDE PAYROLL AND BENEFITS AS A CO-EMPLOYER WITH THE LRA. LRA PAYROLL AND BENEFITS ARE ADMINISTERED BY AMBROSE AS APPROVED BY LRA OFFICERS. LRA PAYROLL IS THEREFORE UNDER THE AMBROSE EIN: 13-3867443 AND W-2'S ARE PREPARED UNDER THAT EIN BY TRINET AMBROSE.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1LUPUS THERAPEUTICS LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line12550 SOUTH CLARK SUITE 670AddressLine1Txt
CityARLINGTONCityNm
State AbbreviationVAStateAbbreviationCd
ZIP22202ZIPCd
FieldValueIRS element (for citing)
EIN823984908EIN
Primary ActivitiesLRA'S SCIENTIFIC PROGRAMSPrimaryActivitiesTxt
Legal Domicile StateVALegalDomicileStateCd
Total Income$1,236,449TotalIncomeAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1YESBusinessNameLine1Txt